Back to top
more

ShockWave Medical (SWAV)

(Real Time Quote from BATS)

$330.11 USD

330.11
438,585

+0.60 (0.18%)

Updated Apr 30, 2024 02:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 46% (136 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for SWAV

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for ShockWave Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 991 305 201 202 195
Receivables 115 71 37 12 7
Notes Receivable 0 0 0 0 0
Inventories 108 75 43 30 12
Other Current Assets 13 8 5 2 2
Total Current Assets 1,225 459 286 246 217
Net Property & Equipment 69 48 24 16 5
Investments & Advances 2 4 6 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 99 98 0 0 0
Intangibles 132 0 0 0 0
Deposits & Other Assets 9 5 2 2 2
Total Assets 1,567 646 346 272 232
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 6 3 7
Accounts Payable 9 7 4 1 3
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 92 55 41 20 14
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 104 63 52 26 24
Mortgages 0 0 0 0 0
Deferred Taxes/Income 4 0 0 0 0
Convertible Debt 732 0 0 0 0
Long-Term Debt 0 24 12 13 7
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 23 12 12 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 898 135 104 46 39
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 558 549 495 469 371
Retained Earnings 110 -37 -253 -244 -178
Other Equity 0 -1 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 669 511 242 226 193
Total Liabilities & Shareholder's Equity 1,567 646 346 272 232
Total Common Equity 669 511 242 226 193
Shares Outstanding 36.90 36.10 35.30 34.20 28.30
Book Value Per Share 18.12 14.16 6.85 6.60 6.81

Fiscal Year End for ShockWave Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 991 917 259 417
Receivables NA 115 99 97 84
Notes Receivable NA 0 0 0 0
Inventories NA 108 97 92 83
Other Current Assets NA 13 15 9 6
Total Current Assets NA 1,225 1,129 456 591
Net Property & Equipment NA 69 62 60 54
Investments & Advances NA 2 2 3 3
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 99 109 95 98
Intangibles NA 132 134 134 0
Deposits & Other Assets NA 9 8 8 6
Total Assets NA 1,567 1,474 787 783
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 9 7 13 11
Current Portion Long-Term Debt NA 0 0 0 80
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 92 70 66 50
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 104 78 80 142
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 4 10 10 0
Convertible Debt NA 732 731 0 0
Long-Term Debt NA 0 0 24 24
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 22 22 12
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 898 873 170 213
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 558 535 586 569
Retained Earnings NA 110 66 31 2
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 669 601 617 571
Total Liabilities & Shareholder's Equity NA 1,567 1,474 787 783
Total Common Equity 0 669 601 617 571
Shares Outstanding 37.40 36.90 36.70 36.60 36.50
Book Value Per Share 0.00 18.12 16.38 16.86 15.64